These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 30093032
21. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer. Chang JE, Yoon IS, Sun PL, Yi E, Jheon S, Shim CK. J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224 [Abstract] [Full Text] [Related]
22. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization. Li G, Cao L, Zhou Z, Chen Z, Huang Y, Zhao Y. Colloids Surf B Biointerfaces; 2015 Apr 01; 128():379-388. PubMed ID: 25779605 [Abstract] [Full Text] [Related]
23. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Guan M, Zhou Y, Zhu QL, Liu Y, Bei YY, Zhang XN, Zhang Q. Nanomedicine; 2012 Oct 01; 8(7):1172-81. PubMed ID: 22321383 [Abstract] [Full Text] [Related]
24. The role of glycyrrhetinic acid modification on preparation and evaluation of quercetin-loaded chitosan-based self-aggregates. Du H, Liu M, Yang X, Zhai G. J Colloid Interface Sci; 2015 Dec 15; 460():87-96. PubMed ID: 26319324 [Abstract] [Full Text] [Related]
26. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. Sayari E, Dinarvand M, Amini M, Azhdarzadeh M, Mollarazi E, Ghasemi Z, Atyabi F. Int J Pharm; 2014 Oct 01; 473(1-2):304-15. PubMed ID: 24905777 [Abstract] [Full Text] [Related]
27. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation. Jeevitha D, Amarnath K. Colloids Surf B Biointerfaces; 2013 Jan 01; 101():126-34. PubMed ID: 22796782 [Abstract] [Full Text] [Related]
28. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Tang P, Sun Q, Zhao L, Pu H, Yang H, Zhang S, Gan R, Gan N, Li H. Carbohydr Polym; 2018 Oct 15; 198():418-425. PubMed ID: 30093018 [Abstract] [Full Text] [Related]
29. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery. Jafary Omid N, Bahari Javan N, Dehpour AR, Partoazar A, Rafiee Tehrani M, Dorkoosh F. Int J Pharm; 2018 Jan 15; 535(1-2):293-307. PubMed ID: 29138048 [Abstract] [Full Text] [Related]
30. Trigonelline-loaded chitosan nanoparticles prompted antitumor activity on glioma cells and biocompatibility with pheochromocytoma cells. Sathiyaseelan A, Saravanakumar K, Jayalakshmi J, Gopi M, Shajahan A, Barathikannan K, Kalaichelvan PT, Wang MH. Int J Biol Macromol; 2020 Nov 15; 163():36-43. PubMed ID: 32585274 [Abstract] [Full Text] [Related]
31. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery. Zhang YW, Tu LL, Tang Z, Wang Q, Zheng GL, Yin LN. Pharm Dev Technol; 2021 Nov 15; 26(9):943-952. PubMed ID: 34372745 [Abstract] [Full Text] [Related]
32. Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells. Quagliariello V, Masarone M, Armenia E, Giudice A, Barbarisi M, Caraglia M, Barbarisi A, Persico M. Oncol Rep; 2019 Mar 15; 41(3):1476-1486. PubMed ID: 30569138 [Abstract] [Full Text] [Related]
33. Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma. Varshosaz J, Fard MM, Mirian M, Hassanzadeh F. Anticancer Agents Med Chem; 2020 Mar 15; 20(3):346-358. PubMed ID: 31566137 [Abstract] [Full Text] [Related]
34. Nano-hybrid carboxymethyl-hexanoyl chitosan modified with (3-aminopropyl)triethoxysilane for camptothecin delivery. Hsiao MH, Tung TH, Hsiao CS, Liu DM. Carbohydr Polym; 2012 Jun 20; 89(2):632-9. PubMed ID: 24750768 [Abstract] [Full Text] [Related]
35. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan. Gupta U, Sharma S, Khan I, Gothwal A, Sharma AK, Singh Y, Chourasia MK, Kumar V. Int J Biol Macromol; 2017 May 20; 98():810-819. PubMed ID: 28189791 [Abstract] [Full Text] [Related]
36. Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery. Zhang Y, Tan X, Ren T, Jia C, Yang Z, Sun H. Carbohydr Polym; 2018 Oct 15; 198():76-85. PubMed ID: 30093044 [Abstract] [Full Text] [Related]
37. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer. Anitha A, Chennazhi KP, Nair SV, Jayakumar R. J Biomed Nanotechnol; 2012 Feb 15; 8(1):29-42. PubMed ID: 22515092 [Abstract] [Full Text] [Related]
38. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery. Yu X, Hou J, Shi Y, Su C, Zhao L. Int J Nanomedicine; 2016 Feb 15; 11():6035-6046. PubMed ID: 27881917 [Abstract] [Full Text] [Related]
39. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer. Tang P, Sun Q, Yang H, Tang B, Pu H, Li H. Int J Pharm; 2018 Jul 10; 545(1-2):74-83. PubMed ID: 29715531 [Abstract] [Full Text] [Related]
40. Cytotoxicity and apoptotic effects of tea polyphenol-loaded chitosan nanoparticles on human hepatoma HepG2 cells. Liang J, Li F, Fang Y, Yang W, An X, Zhao L, Xin Z, Cao L, Hu Q. Mater Sci Eng C Mater Biol Appl; 2014 Mar 01; 36():7-13. PubMed ID: 24433880 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]